Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 17 Schemes (11.77%)
Foreign Institutions
Held by 33 Foreign Institutions (16.89%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-8 Million
Pharmaceuticals & Biotechnology
USD 92 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
2.01
-999,999.00%
-5.00






